Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: A nationwide population-based cohort study in Denmark

The Lancet HIV

Volumn 2, Issue 8, 2015, Pages e344-e350

  Helleberg, Marie ^a,b   Pedersen, Marianne G ^c,e,f   Pedersen, Carsten B ^c,d,e,f   Mortensen, Preben B ^c,d,e,f   Obel, Niels ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c National Centre for Register based Research   (Denmark)

^d Centre for Integrated Registerbased Research   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ;

ACUTE PSYCHOSIS; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DENMARK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT RESPONSE; YOUNG ADULT; ADDICTION; COMPLICATION; HIV INFECTIONS; INCIDENCE; MORTALITY; PSYCHOTIC DISORDERS; REGISTER; RISK FACTOR;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PSYCHOTIC DISORDERS; REGISTRIES; RISK FACTORS; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84947019306     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00089-2     Document Type: Article

References (28)

1. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs 2006; 66: 769-89.
2. Himelhoch S, Josephs JS, Chander G, Korthuis PT, Gebo KA. Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study. Gen Hosp Psychiatry 2009; 31: 538-45.
3. Justice AC, McGinnis KA, Atkinson JH, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: veterans aging cohort fi ve-site study. AIDS 2004; (suppl 1): S49-59.
4. Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO. Human immunodefi ciency virus type 1 infection of the brain. Clin Microbiol Rev 1993; 6: 339-66.
5. Arendt G, de Nocker D, von Giesen HJ, Nolting T. Neuropsychiatric side eff ects of efavirenz therapy. Expert Opin Drug Saf 2007; 6: 147-54.
6. Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 2010; 376: 268-84.
7. Milloy MJ, Montaner J, Wood E. Barriers to HIV treatment among people who use injection drugs: implications for 'treatment as prevention'. Curr Opin HIV AIDS 2012; 7: 332-38.
8. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-49.
9. Mors O, Perto GP, Mortensen PB. The Danish psychiatric central research register. Scand J Public Health 2011; 39 (suppl 7): 54-57.
10. Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health 2011; 39 (suppl 7): 30-33.
11. WHO. Classification of diseases: extended Danish-Latin version of the World Health Organization International Classifi cation of Diseases, 8th revision, 1965. Copenhagen: Danish National Board of Health, 1971 (in Danish).
12. WHO. The ICD-10 classification of mental and behavioural disorders. Diagnostic Criteria for Research. 1st edn. Geneva: World Health Organization, 1993.
13. Omland LH, Ahlstrom MG, Obel N. Cohort profile update: the Danish HIV cohort Study (DHCS). Int J Epidemiol 2014; 43: 1769-9e.
14. Helleberg M, Kronborg G, Larsen CS, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection 2012; 40: 627-34.
15. Mirza RA, Eick-Cost A, Otto JL. The risk of mental health disorders among US military personnel infected with human immunodeficiency virus, active component, US Armed Forces, 2000-2011. MSMR 2012; 19: 10-13.
16. Jones GH, Kelly CL, Davies JA. HIV and onset of schizophrenia. Lancet 1987; 1: 982.
17. Helleberg M, Kirk O. Encephalitis in primary HIV infection: challenges in diagnosis and treatment. Int J STD AIDS 2013; 24: 489-93.
18. de la Garza CL, Paoletti-Duarte S, Garcia-Martin C, Gutierrez-Casares JR. Efavirenz-induced psychosis. AIDS 2001; 15: 1911-12.
19. Prince JD, Walkup J, Akincigil A, Amin S, Crystal S. Serious mental illness and risk of new HIV/AIDS diagnoses: an analysis of Medicaid beneficiaries in eight states. Psychiatr Serv 2012; 63: 1032-38.
20. Cournos F, Guimaraes MD, Wainberg ML. HIV/AIDS and serious mental illness: a risky conclusion. Psychiatr Serv 2012; 63: 1261-62.
21. Ostman M, Bjorkman AC. Schizophrenia and relationships: the effect of mental illness on sexuality. Clin Schizophr Relat Psychoses 2013; 7: 20-24.
22. Nimgaonkar VL. Reduced fertility in schizophrenia: here to stay? Acta Psychiatr Scand 1998; 98: 348-53.
23. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol 2014; 10: 425-48.
24. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012; 25: 83-88.
25. Uggerby P, Ostergaard SD, Roge R, Correll CU, Nielsen J. The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good. Dan Med J 2013; 60: A4578.
26. Jakobsen KD, Frederiksen JN, Hansen T, Jansson LB, Parnas J, Werge T. Reliability of clinical ICD-10 schizophrenia diagnoses. Nord J Psychiatry 2005; 59: 209-12.
27. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol 2009; 38: 1202-06.
28. Cantor-Graae E, Pedersen CB. Full spectrum of psychiatric disorders related to foreign migration: a Danish population-based cohort study. JAMA Psychiatry 2013; 70: 427-35.